Terms: = Lymphoma AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Prognosis
31 results:
1. Novel identification of t(14;18)(q32;q21)/IGH::MALT1 in chronic lymphocytic leukaemia.
Kumar J; Ewalt MD; Zhang Y; Yao J; Thompson MC; Dogan A
Br J Haematol; 2024 Feb; 204(2):561-565. PubMed ID: 38031233
[TBL] [Abstract] [Full Text] [Related]
2. Impact of C-reactive protein and albumin levels on short, medium, and long term mortality in patients with diffuse large B-cell lymphoma.
Gradel KO; Larsen TS; Frederiksen H; Vinholt PJ; Iachina M; Póvoa P; Zampieri FG; Nielsen SL; Dessau RB; Møller JK; Jensen TG; Chen M; Coia JE; Jelicic J
Ann Med; 2022 Dec; 54(1):713-722. PubMed ID: 35238275
[No Abstract] [Full Text] [Related]
3. The Discovery of a Novel Antimetastatic bcl3 Inhibitor.
Soukupová J; Bordoni C; Turnham DJ; Yang WW; Seaton G; Gruca A; French R; Lee KY; Varnava A; Piggott L; Clarkson RWE; Westwell AD; Brancale A
Mol Cancer Ther; 2021 May; 20(5):775-786. PubMed ID: 33649105
[TBL] [Abstract] [Full Text] [Related]
4. PCAT1 induced by transcription factor YY1 promotes cholangiocarcinoma proliferation, migration and invasion by sponging miR-216a-3p to up-regulate oncogene bcl3.
Sun D; Zhao Y; Wang W; Guan C; Hu Z; Liu L; Jiang X
Biol Chem; 2021 Jan; 402(2):207-219. PubMed ID: 33544468
[TBL] [Abstract] [Full Text] [Related]
5. The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B-cell lymphoma.
Habbous S; Guo H; Beca J; Dai WF; Isaranuwatchai W; Cheung M; Chan KKW
Cancer Med; 2020 Oct; 9(19):7072-7082. PubMed ID: 32794362
[TBL] [Abstract] [Full Text] [Related]
6. BCL‑3 promotes cyclooxygenase‑2/prostaglandin E2 signalling in colorectal cancer.
Collard TJ; Fallatah HM; Greenhough A; Paraskeva C; Williams AC
Int J Oncol; 2020 May; 56(5):1304-1313. PubMed ID: 32319612
[TBL] [Abstract] [Full Text] [Related]
7. The role of B-Cell lymphoma-3 (BCL-3) in enabling the hallmarks of cancer: implications for the treatment of colorectal carcinogenesis.
Legge DN; Chambers AC; Parker CT; Timms P; Collard TJ; Williams AC
Carcinogenesis; 2020 May; 41(3):249-256. PubMed ID: 31930327
[TBL] [Abstract] [Full Text] [Related]
8. Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and bcl3) is Associated With Clinical Outcome of NSCLC Patients.
Dimitrakopoulos FD; Antonacopoulou AG; Kottorou AE; Panagopoulos N; Kalofonou F; Sampsonas F; Scopa C; Kalofonou M; Koutras A; Makatsoris T; Dougenis D; Papadaki H; Brock M; Kalofonos HP
Sci Rep; 2019 Oct; 9(1):14299. PubMed ID: 31586084
[TBL] [Abstract] [Full Text] [Related]
9. [Advanced Pneumonic-type Lung Carcinoma: A Retrospective Study of Clinical-radiological-pathological Characteristics with Survival Analysis in A Single Chinese Hospital].
Liu Y; Li J; Wang S; Chen M; Zhao J; Jiang D; Zhong W; Xu Y; Wang M
Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):329-335. PubMed ID: 31196365
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic and predictive value of a microRNA signature in adults with T-cell lymphoblastic lymphoma.
Tian XP; Huang WJ; Huang HQ; Liu YH; Wang L; Zhang X; Lin TY; Rao HL; Li M; Liu F; Zhang F; Zhong LY; Liang L; Lan XL; Li J; Liao B; Li ZH; Tang QL; Liang Q; Shao CK; Zhai QL; Cheng RF; Sun Q; Ru K; Gu X; Lin XN; Yi K; Shuang YR; Chen XD; Dong W; Sang W; Sun C; Liu H; Zhu ZG; Rao J; Guo QN; Zhou Y; Meng XL; Zhu Y; Hu CL; Jiang YR; Zhang Y; Gao HY; He WJ; Xia ZJ; Wu CL; Zhang MY; Wang HY; Xie D; Cai QQ
Leukemia; 2019 Oct; 33(10):2454-2465. PubMed ID: 30953029
[TBL] [Abstract] [Full Text] [Related]
11. bcl3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.
Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
[TBL] [Abstract] [Full Text] [Related]
12. Bcl-3 promotes proliferation and chemosensitivity in BL1 subtype of TNBC cells.
Huo J; Chen X; Zhang H; Hu Y; Jiang Y; Liu S; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2018 Nov; 50(11):1141-1149. PubMed ID: 30289427
[TBL] [Abstract] [Full Text] [Related]
13. Molecular Markers and prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis.
Lee YC; Hsieh CC; Lee YL; Li CY
Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):558-568. PubMed ID: 29970342
[TBL] [Abstract] [Full Text] [Related]
14. Clinical significance of chemokine receptor CXCR4 and mammalian target of rapamycin (mTOR) expression in patients with diffuse large B-cell lymphoma.
Xu ZZ; Shen JK; Zhao SQ; Li JM
Leuk Lymphoma; 2018 Jun; 59(6):1451-1460. PubMed ID: 28952842
[TBL] [Abstract] [Full Text] [Related]
15. T cells bearing anti-CD19 and/or anti-CD38 chimeric antigen receptors effectively abrogate primary double-hit lymphoma cells.
Mihara K; Yoshida T; Takei Y; Sasaki N; Takihara Y; Kuroda J; Ichinohe T
J Hematol Oncol; 2017 Jun; 10(1):116. PubMed ID: 28595585
[TBL] [Abstract] [Full Text] [Related]
16. [Value of Pretherapeutic
Ding CY; Liu HY; Guo Z; Li TN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):438-443. PubMed ID: 28446289
[TBL] [Abstract] [Full Text] [Related]
17. Burkitt cells on a peripheral blood smear: how to deal with?
Wyrwas M; Michel J; Guibaud I; Lesesve JF; Bénet B
Ann Biol Clin (Paris); 2016 Dec; 74(6):697-703. PubMed ID: 27848920
[TBL] [Abstract] [Full Text] [Related]
18. A four-gene signature predicts survival in clear-cell renal-cell carcinoma.
Dai J; Lu Y; Wang J; Yang L; Han Y; Wang Y; Yan D; Ruan Q; Wang S
Oncotarget; 2016 Dec; 7(50):82712-82726. PubMed ID: 27779101
[TBL] [Abstract] [Full Text] [Related]
19. [Clinical characteristics and survival of newly diagnosed multiple myeloma patients under 40 years old from single center and literature review].
Feng X; Deng S; An G; Qin X; Sui W; Zou D; Qiu L; Xu Y
Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):933-6. PubMed ID: 26632466
[TBL] [Abstract] [Full Text] [Related]
20. Variant of bcl3 gene is strongly associated with five-year survival of non-small-cell lung cancer patients.
Dimitrakopoulos FI; Antonacopoulou AG; Kottorou A; Marousi S; Koukourikou I; Kalofonou M; Panagopoulos N; Scopa C; Dougenis D; Papadaki H; Papavassiliou AG; Kalofonos HP
Lung Cancer; 2015 Sep; 89(3):311-9. PubMed ID: 26122346
[TBL] [Abstract] [Full Text] [Related]
[Next]
